Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma
Open Access
- 1 February 1992
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 65 (2) , 303-304
- https://doi.org/10.1038/bjc.1992.61
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanomaBritish Journal of Cancer, 1990
- Phase II study of bleomycin, dacarbazine (DTIC) and vindesine in disseminated malignant melanomaZeitschrift für Krebsforschung und Klinische Onkologie, 1989
- INTERFERON EFFECTS UPON THE ADENOCARCINOMA-38 AND HL-60 CELL-LINES - ANTIPROLIFERATIVE RESPONSES AND SYNERGISTIC INTERACTIONS WITH HALOGENATED PYRIMIDINE ANTIMETABOLITES1988
- Three consecutive phase II studies of recombinant interferon alfa–2a in advanced malignant melanoma. Updated analysesCancer, 1987